Senior insider sale
Chief Corp Dev & Strategy at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$85.8K
2.96K shares
What this filing means
VISWANADHAN KRISHNAN plans to sell 2.96K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $85.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2026ACC: 0001439222-26-000047
Officer· Chief Corp Dev & Strategy
Since Mar 2026
2.96K
Shares to sell
$85.8K
Approx. market value
2.96K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
Not Applicable
3/5/2026
2.96KTotal acquired2.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2026 | Vesting of Restricted Stock Units Not Applicable | 2.96K | — |
| Total | 2.96K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
2.96K
Market value
$85.8K
3/5/2026
Total
Units
2.96K
Value
$85.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/5/2026 | 2.96K | $85.8K | Nasdaq | Planned |
| Total | 2.96K | $85.8K | ||